215 related articles for article (PubMed ID: 17318223)
1. Haploinsufficiency of Parp1 accelerates Brca1-associated centrosome amplification, telomere shortening, genetic instability, apoptosis, and embryonic lethality.
Wang X; Liu L; Montagna C; Ried T; Deng CX
Cell Death Differ; 2007 May; 14(5):924-31. PubMed ID: 17318223
[TBL] [Abstract][Full Text] [Related]
2. Genetic interactions between Brca1 and Gadd45a in centrosome duplication, genetic stability, and neural tube closure.
Wang X; Wang RH; Li W; Xu X; Hollander MC; Fornace AJ; Deng CX
J Biol Chem; 2004 Jul; 279(28):29606-14. PubMed ID: 15123655
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 and CtIP promote alternative non-homologous end-joining at uncapped telomeres.
Badie S; Carlos AR; Folio C; Okamoto K; Bouwman P; Jonkers J; Tarsounas M
EMBO J; 2015 Feb; 34(3):410-24. PubMed ID: 25582120
[TBL] [Abstract][Full Text] [Related]
4. DNA repair factors and telomere-chromosome integrity in mammalian cells.
Hande MP
Cytogenet Genome Res; 2004; 104(1-4):116-22. PubMed ID: 15162024
[TBL] [Abstract][Full Text] [Related]
5. ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency.
Cao L; Kim S; Xiao C; Wang RH; Coumoul X; Wang X; Li WM; Xu XL; De Soto JA; Takai H; Mai S; Elledge SJ; Motoyama N; Deng CX
EMBO J; 2006 May; 25(10):2167-77. PubMed ID: 16675955
[TBL] [Abstract][Full Text] [Related]
6. PARP1 Is a TRF2-associated poly(ADP-ribose)polymerase and protects eroded telomeres.
Gomez M; Wu J; Schreiber V; Dunlap J; Dantzer F; Wang Y; Liu Y
Mol Biol Cell; 2006 Apr; 17(4):1686-96. PubMed ID: 16436506
[TBL] [Abstract][Full Text] [Related]
7. Enhanced susceptibility of ovaries from obese mice to 7,12-dimethylbenz[a]anthracene-induced DNA damage.
Ganesan S; Nteeba J; Keating AF
Toxicol Appl Pharmacol; 2014 Dec; 281(2):203-10. PubMed ID: 25448685
[TBL] [Abstract][Full Text] [Related]
8. Biological and clinical significance of PARP1 protein expression in breast cancer.
Green AR; Caracappa D; Benhasouna AA; Alshareeda A; Nolan CC; Macmillan RD; Madhusudan S; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2015 Jan; 149(2):353-62. PubMed ID: 25528020
[TBL] [Abstract][Full Text] [Related]
9. Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci.
Huber LJ; Yang TW; Sarkisian CJ; Master SR; Deng CX; Chodosh LA
Mol Cell Biol; 2001 Jun; 21(12):4005-15. PubMed ID: 11359908
[TBL] [Abstract][Full Text] [Related]
10. PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis.
Rybanska I; Ishaq O; Chou J; Prakash M; Bakhsheshian J; Huso DL; Franco S
Oncogene; 2013 Apr; 32(14):1761-71. PubMed ID: 22614020
[TBL] [Abstract][Full Text] [Related]
11. Absence of full-length Brca1 sensitizes mice to oxidative stress and carcinogen-induced tumorigenesis in the esophagus and forestomach.
Cao L; Xu X; Cao LL; Wang RH; Coumoul X; Kim SS; Deng CX
Carcinogenesis; 2007 Jul; 28(7):1401-7. PubMed ID: 17363841
[TBL] [Abstract][Full Text] [Related]
12. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
[TBL] [Abstract][Full Text] [Related]
13. A novel crosstalk between BRCA1 and poly (ADP-ribose) polymerase 1 in breast cancer.
Li D; Bi FF; Chen NN; Cao JM; Sun WP; Zhou YM; Li CY; Yang Q
Cell Cycle; 2014; 13(21):3442-9. PubMed ID: 25485588
[TBL] [Abstract][Full Text] [Related]
14. PARP inhibitors suppress tumours via centrosome error-induced senescence independent of DNA damage response.
Yue W; Li X; Zhan X; Wang L; Ma J; Bi M; Wang Q; Gu X; Xie B; Liu T; Guo H; Zhu X; Song C; Qiao J; Li M
EBioMedicine; 2024 May; 103():105129. PubMed ID: 38640836
[TBL] [Abstract][Full Text] [Related]
15. Enhanced non-homologous end joining contributes toward synthetic lethality of pathological RAD51C mutants with poly (ADP-ribose) polymerase.
Somyajit K; Mishra A; Jameei A; Nagaraju G
Carcinogenesis; 2015 Jan; 36(1):13-24. PubMed ID: 25292178
[TBL] [Abstract][Full Text] [Related]
16. Impact of telomerase ablation on organismal viability, aging, and tumorigenesis in mice lacking the DNA repair proteins PARP-1, Ku86, or DNA-PKcs.
Espejel S; Klatt P; Ménissier-de Murcia J; Martín-Caballero J; Flores JM; Taccioli G; de Murcia G; Blasco MA
J Cell Biol; 2004 Nov; 167(4):627-38. PubMed ID: 15545322
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune response to PARP and BRCA1/BRCA2 in cancer.
Zhu Q; Han SX; Zhou CY; Cai MJ; Dai LP; Zhang JY
Oncotarget; 2015 May; 6(13):11575-84. PubMed ID: 25865228
[TBL] [Abstract][Full Text] [Related]
18. Haploinsufficiency of poly(ADP-ribose) polymerase-1-mediated poly(ADP-ribosyl)ation for centrosome duplication.
Kanai M; Tong WM; Wang ZQ; Miwa M
Biochem Biophys Res Commun; 2007 Aug; 359(3):426-30. PubMed ID: 17553458
[TBL] [Abstract][Full Text] [Related]
19. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX
Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698
[TBL] [Abstract][Full Text] [Related]
20. A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint.
Wang RH; Yu H; Deng CX
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17108-13. PubMed ID: 15563594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
